Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

Lite Strategyについて

設立2018
Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.
コミュニティ
Twitter
Website
タグ
Publicly listed company
Crypto Stocks

ホットインデックス変動トレンド

データなし

チームメンバー

Frederick W. Driscoll
Frederick W. Driscoll

Chairperson and Non-Executive Director

Justin (Jay) File
Justin (Jay) File

Chief Executive Officer and Chief Financial Officer

資金調達の詳細

Post-IPO(2025-07-21)
金額¥16.12B
評価額--